Last: | $84.61 |
---|---|
Change Percent: | -0.19% |
Open: | $84.5 |
Close: | $84.61 |
High: | $85.49 |
Low: | $83.89 |
Volume: | 879,775 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$84.61 | $84.5 | $84.61 | $85.49 | $83.89 | 879,775 | 04-26-2024 |
$84.34 | $84.87 | $84.34 | $84.895 | $82.93 | 1,236,553 | 04-25-2024 |
$85.14 | $84.88 | $85.14 | $85.52 | $84.188 | 1,065,985 | 04-24-2024 |
$85.43 | $84.37 | $85.43 | $86.02 | $84.25 | 993,864 | 04-23-2024 |
$84.89 | $83.8 | $84.89 | $85.5 | $83.395 | 1,186,998 | 04-22-2024 |
$83.97 | $83.56 | $83.97 | $84.3 | $83.43 | 793,087 | 04-19-2024 |
$83.6 | $84.18 | $83.6 | $84.58 | $82.95 | 1,000,733 | 04-18-2024 |
$82.85 | $83.74 | $82.85 | $83.82 | $82.37 | 1,071,124 | 04-17-2024 |
$82.96 | $82.07 | $82.96 | $84.31 | $81.85 | 1,656,521 | 04-16-2024 |
$82.59 | $84.01 | $82.59 | $84.74 | $81.75 | 1,237,264 | 04-15-2024 |
$83.61 | $86.14 | $83.61 | $86.215 | $82.81 | 1,523,527 | 04-12-2024 |
$86.57 | $87 | $86.57 | $87.6 | $85.56 | 1,958,297 | 04-11-2024 |
$86.2 | $85.25 | $86.2 | $86.39 | $85.23 | 1,509,505 | 04-10-2024 |
$86.38 | $85.86 | $86.38 | $86.44 | $85.25 | 950,130 | 04-09-2024 |
$85.09 | $83.84 | $85.09 | $85.12 | $83.295 | 1,833,111 | 04-08-2024 |
$83.34 | $83.44 | $83.34 | $83.645 | $82.73 | 838,580 | 04-05-2024 |
$83.86 | $86 | $83.86 | $86.27 | $83.69 | 1,106,621 | 04-04-2024 |
$85.5 | $84.35 | $85.5 | $85.82 | $84.35 | 1,694,270 | 04-03-2024 |
$84.25 | $86.16 | $84.25 | $86.19 | $83.71 | 1,653,945 | 04-02-2024 |
$86.37 | $86.27 | $86.37 | $86.72 | $85.25 | 1,580,223 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Internationa Flavors & Fragrances Inc. Company Name:
IFF Stock Symbol:
NYSE Market:
IFF to Showcase Science-backed Low Nitrite Excipients at Excipient World 2024 PR Newswire Experts will present risk assessment strategies for nitrite detection and quality evaluation to promote safer pharmaceutical formulations with better patient outcomes NEW YORK ...
2024-04-19 06:30:07 ET Barclays analyst issues EQUAL-WEIGHT recommendation for IFF on April 19, 2024 04:33AM ET. The previous analyst recommendation was Underweight. IFF was trading at $83.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
IFF (NYSE:IFF) today announced that it will release its first quarter 2024 earnings results following the market close on Monday, May 6, 2024. The management team will host a live webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Inves...